Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
BAL PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

BAL PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹38 Cr₹45 Cr₹38 Cr₹36 Cr₹34 Cr

What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?

The latest Total Non-Current Liabilities ratio of BAL PHARMA is ₹38 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹38 Cr
Mar2024₹45 Cr
Mar2023₹38 Cr
Mar2022₹36 Cr
Mar2021₹34 Cr

How is Total Non-Current Liabilities of BAL PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹38 Cr
-14.36
Mar2024 ₹45 Cr
18.02
Mar2023 ₹38 Cr
4.32
Mar2022 ₹36 Cr
6.44
Mar2021 ₹34 Cr -

Compare Total Non-Current Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹108.2 Cr 1.6% -11.3% -21.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹98,767.6 Cr -3.3% -6.9% -17% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

1.6%

-11.3%

-21.9%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses